precision medicine companies

Companies whose enriched business profile is tagged “precision medicine”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date.

• Thermo Fisher Scientific (TMO) Health Care — Global leader in life sciences tools, diagnostics, and laboratory services supporting research, diagnostics, and bioproduction across pharma, biotech, and clinical markets. ask →
• Vertex Pharmaceuticals (VRTX) Health Care — Vertex Pharmaceuticals develops transformative medicines for serious genetic diseases, with a dominant pipeline anchored in cystic fibrosis treatments and groundbreaking gene-editing therapies for blood disorders and pain. ask →
• Alnylam Pharmaceuticals (ALNY) Health Care — A commercial-stage RNAi therapeutics pioneer with six FDA-approved siRNA medicines targeting rare genetic and cardiometabolic diseases. ask →
• GE HealthCare (GEHC) Health Care — Global healthcare technology leader delivering medical imaging systems, diagnostic solutions, and AI-enabled software to help clinicians diagnose and treat complex diseases. ask →
• PTC THERAPEUTICS INC (PTCT) Health Care — PTC Therapeutics develops precision medicines and gene therapies targeting rare genetic disorders and serious diseases, generating revenue from approved products and partnered collaboration deals. ask →
• VERACYTE INC (VCYT) Health Care — Veracyte is a genomic diagnostics company that develops and commercializes molecular tests to guide treatment decisions in cancer and other serious diseases. ask →
• DYNE THERAPEUTICS INC (DYN) Health Care — A clinical-stage biotechnology company developing precision medicines using its proprietary FORCE platform to treat muscle and neurological diseases. ask →
• BEAM THERAPEUTICS INC (BEAM) Health Care — Beam Therapeutics is developing base editing medicines—a precision genetic cure approach—for serious inherited diseases like sickle cell disease and rare genetic disorders. ask →
• MONTE ROSA THERAPEUTICS INC (GLUE) Health Care — Monte Rosa Therapeutics develops molecular glue degraders—a novel class of protein degradation drugs targeting historically undruggable proteins through its proprietary QuEEN discovery platform. ask →
• RECURSION PHARMACEUTICALS INC CLAS (RXRX) Health Care — Recursion is a clinical-stage AI-native drug discovery platform that uses machine learning and biological datasets to rapidly identify and develop novel medicines. ask →
• PRECIGEN INC (PGEN) Health Care — Gene therapy precision medicine company with FDA-approved adenoviral immunotherapy for HPV-driven respiratory disease and a development pipeline of CAR-T and viral vector candidates across oncology and infectious disease. ask →
• NAUTILUS BIOTECHNOLGY INC (NAUT) Health Care — A pre-commercial proteomics platform company developing Iterative Mapping technology to enable single-molecule protein counting for comprehensive, reproducible characterization of the proteome at scale. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-07-10.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.